Shauna Richardson
Psychiatric/Mental Health · Kenosha, WINPI 1447206511
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 97.2% of the total across 426 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 32 manufacturers, the largest accounting for just 15.6% — the pattern of someone who eats at a lot of different presentations. Among psychiatric/mental health clinicians in WI with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 426 payments — averaging $16.19 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Supernus Pharmaceuticals, Inc.$1K
- Alkermes, Inc.$1K
- Johnson & Johnson$602
- Teva Pharmaceuticals USA, Inc.$508
- AbbVie$503
- Axsome Therapeutics, Inc.$404
- plus $3K from 26 others
What the payments were for
- Food & beverage$6,70297%
- Education$1943%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Supernus Pharmaceuticals, Inc. | 87 | $1,073 |
| Alkermes, Inc. | 50 | $1,032 |
| Johnson & Johnson | 38 | $602 |
| Teva Pharmaceuticals USA, Inc. | 27 | $508 |
| AbbVie | 41 | $503 |
| Axsome Therapeutics, Inc. | 25 | $404 |
| Sunovion Pharmaceuticals Inc. | 28 | $358 |
| Takeda Pharmaceuticals U.S.A., Inc. | 22 | $322 |
| Otsuka America Pharmaceutical, Inc. | 17 | $291 |
| Harmony Biosciences LLC | 11 | $279 |
| Neurocrine Biosciences, Inc. | 12 | $240 |
| Lundbeck LLC | 9 | $190 |
| Vanda Pharmaceuticals Inc. | 7 | $185 |
| Corium, LLC | 10 | $148 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 5 | $137 |
| OWP Pharmaceuticals, Inc. | 5 | $74 |
| Noven Therapeutics, LLC | 3 | $58 |
| E.r. Squibb & Sons, L.L.C. | 3 | $57 |
| Ironshore Pharmaceuticals Inc. | 3 | $56 |
| Indivior Inc. | 4 | $56 |
| Neos Therapeutics, LP | 3 | $51 |
| Bausch Health US, LLC | 2 | $42 |
| Lilly USA, LLC | 2 | $39 |
| Idorsia Pharmaceuticals US Inc | 2 | $31 |
| Tris Pharma Inc | 2 | $28 |
| Merck | 2 | $25 |
| Neuronetics, Inc. | 1 | $23 |
| Adlon Therapeutics L.p. | 1 | $18 |
| Novo Nordisk | 1 | $18 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $17 |
| USWM, LLC | 1 | $15 |
| Jazz Pharmaceuticals Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- LYBALVI$960
How this compares
$6,896 in reported general payments places this provider in the 95th percentile of 384 psychiatric/mental health providers in Wisconsin.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| AustedoDeutetrabenazine | 11 | $133,669 |
| VraylarCariprazine Hcl | 65 | $101,662 |
| Invega SustennaPaliperidone Palmitate | 30 | $83,441 |
| LybalviOlanzapine/Samidorphan Malate | 21 | $45,046 |
| VyvanseLisdexamfetamine Dimesylate | 60 | $30,660 |
| RexultiBrexpiprazole | 12 | $30,166 |
| QuviviqDaridorexant Hcl | 18 | $9,727 |
| Clozapine | 118 | $7,638 |
| Aripiprazole | 134 | $7,166 |
| Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine | 49 | $5,148 |
| Olanzapine | 113 | $4,814 |
| SavellaMilnacipran Hcl | 12 | $3,920 |
| Lisdexamfetamine Dimesylate | 20 | $3,751 |
| Duloxetine Hcl | 144 | $3,699 |
| Ziprasidone Hcl | 45 | $3,673 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Teva Pharmaceuticals USA, Inc.Austedo | $508 | $133,66911 claims |
| AbbVieVraylar, Savella | $503 | $105,58177 claims |
| Johnson & JohnsonInvega Sustenna | $602 | $83,44130 claims |
| Alkermes, Inc.Lybalvi | $1,032 | $45,04621 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Vyvanse | $322 | $30,66060 claims |
| Otsuka America Pharmaceutical, Inc.Rexulti | $291 | $30,16612 claims |
| Idorsia Pharmaceuticals US IncQuviviq | $31 | $9,72718 claims |
| Lilly USA, LLCOlanzapine | $39 | $4,814113 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 384 psychiatric/mental health providers in Wisconsin.
Other psychiatric/mental health in Kenosha
- Alyssa SkalitzkyKenosha$8K
- Tilly BurroughsKenosha$6K
- Alexandria DattiloKenosha$6K
- Christine TurcotteKenosha$5K
- Carolyn DavidsonMilwaukee$46K
- Sherry AleksichMilwaukee$33K
- Bobbi DurstPewaukee$23K
- Ngozi ObioraMilwaukee$19K
- Glenda McConnellGreen Bay$14K
- Debra BenishekGreen Bay$12K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.